CRI Funded Scientists
CRI invests in the brightest people with the best ideas all around the world.
These current and future scientific leaders in immunology and tumor immunology, from top academic research institutions, are advancing fundamental and applied discoveries that impact cancer research. From bench to bedside, CRI is ushering in the next generation of cancer immunotherapy innovations.
Search for CRI Funded Scientists using the filters below:
Mark Chong, PhD
St. Vincent’s Hospital Applied Medical Research Institute
Tech Impact Award
Alexis Combes, PhD
University of California, San Francisco
Tech Impact Award
Ang Cui, PhD
Mass General Brigham
Tech Impact Award
Arpita Desai, MD
University of California, San Francisco
Tech Impact Award
Nadia Guerra, PhD
Imperial College London
Tech Impact Award
Masakazu Kamata, PhD
University of Alabama at Birmingham
Tech Impact Award
Ayano Kohlgruber, PhD
Boston Children’s Hospital
Tech Impact Award
Matthew Krummel, PhD
University of California, San Francisco
Tech Impact Award
Rik G.H. Lindeboom, PhD
The Netherlands Cancer Institute
Tech Impact Award
Robert Manguso, PhD
Massachusetts General Hospital
Tech Impact Award
Yifat Merbl, PhD
Weizmann Institute of Science
CRI Lloyd J. Old STAR, Tech Impact Award
Karin Pelka, PhD
The J. David Gladstone Institutes
Tech Impact Award
Daniel Puleston, PhD
Icahn School of Medicine at Mount Sinai
Tech Impact Award
Debattama Sen, PhD
Massachusetts General Hospital
Tech Impact Award
Allon Wagner, PhD
University of California, Berkeley
Tech Impact Award